A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

NCT07660614 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: LTX-002
OTHER: Placebo (aCSF)

Sponsor

Leal Therapeutics, Inc